One of the major challenges in cancer treatment is the development of drug resistance,which can render traditional therapies ineffective.A potential solution to this problem is to target cancer cells by rupturing their plasma membranes.Plasma membrane rupture is a process in which the outer membrane of a cell is disrupted,leading to the death of the cell.However,the low tumor selectivity of existing membranolytic molecules has limited their application in cancer treatment.
展开▼
